ICNS 2024 & MDD 2024 Forum
From August 29th to 30th, 2024, the highly anticipated ICNS 2024 Fourth Central Nervous System Drugs In-depth Focus Forum and MDD 2024 Metabolic Diseases and Weight Loss Drug Development Forum, which have attracted much attention in the pharmaceutical industry, concluded successfully in Nanjing, China. At this grand event that brings together industry elites and cutting-edge ideas, our company, as an active conference participant, is deeply integrated into it, witnessing and promoting industry exchanges and development with colleagues from all walks of life.
The ICNS 2024 Fourth Central Nervous System Drugs In-depth Focus Forum was lively and full of useful information. More than 80 experts in the field of CNS appeared one after another, and more than 1,200 industry elites gathered here to jointly start an in-depth dialogue on the road to new drug research and development. With their profound professional knowledge and rich practical experience, the experts shared many valuable experiences, challenges and coping strategies in the development of central nervous system drugs. Everyone spoke freely, and sparks from the collision of ideas flew in the venue, working together to contribute to the vigorous development of the domestic CNS industry.
The MDD metabolic disease and weight loss drug development forum is also star-studded. The forum successfully attracted 40+ representatives from leading companies. They brought their experience and insights accumulated in the industry to gather together with 1,200+ industry colleagues. Everyone had a lively and in-depth discussion around the development cases and trends in multiple key areas such as weight loss drugs, diabetes drugs, NASH drugs, and gout drugs. The actual development cases shared by various representatives are like beacons, illuminating the direction for subsequent drug research and development work in the industry; and the precise analysis of trends is like a compass, helping everyone find the right direction in the ever-changing pharmaceutical market. This has undoubtedly injected new vitality and ideas into the entire field of metabolic disease and weight loss drug development.
The team members of our company who participated in this meeting were fully engaged in all aspects, actively communicating with their peers and exchanging knowledge. On the one hand, we listen carefully to the wonderful sharings of experts and business representatives, and learn advanced concepts and cutting-edge technologies; on the other hand, we also actively demonstrate our company’s achievements in related fields and our own unique advantages to the outside world, seeking more cooperation. opportunities, and strive to contribute more of our company's strength to the development of the pharmaceutical industry in the future.
I believe that through the successful holding of the ICNS 2024 and MDD 2024 forums and the joint efforts of many people in the industry, the domestic central nervous system drugs, metabolic diseases and weight loss drug development fields will usher in broader development prospects, and our company will also Keep up with the pace of industry development, continue to forge ahead, and create more successes.